HighTower Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $765K | Sell |
|
|||||
|
2024
Q2 | $1.38M | Buy |
|
|||||
|
2024
Q1 | $2.19M | Buy |
|
|||||
|
2023
Q4 | $3.57M | Buy |
|
|||||
|
2023
Q3 | $3.32M | Buy |
|
|||||
|
2023
Q2 | $4.94M | Sell |
|
|||||
|
2023
Q1 | $9.83M | Sell |
|
|||||
|
2022
Q4 | $9.07M | Sell |
|
|||||
|
2022
Q3 | $23.1M | Sell |
|
|||||
|
2022
Q2 | $16.9M | Sell |
|
|||||
|
2022
Q1 | $24M | Buy |
|
|||||
|
2021
Q4 | $15.8M | Buy |
|
|||||
|
2021
Q3 | $24M | Buy |
|
|||||
|
2021
Q2 | $17.3M | Sell |
|
|||||
|
2021
Q1 | $19.2M | Buy |
|
|||||
|
2020
Q4 | $2.06M | Sell |
|
|||||
|
2020
Q3 | $2.44M | Buy |
|
|||||
|
2020
Q2 | $1.2M | Buy |
|
|||||
|
2020
Q1 | $648K | Buy |
|
|||||
|
2019
Q4 | $665K | Buy |
|
|||||
|
2019
Q3 | $367K | Buy |
|
|||||
|
2019
Q2 | $352K | Buy |
|
|||||
|
2019
Q1 | $410K | Buy |
|
|||||
|
2018
Q4 | $403K | Sell |
|
|||||
|
2018
Q3 | $547K | Hold |
|
|||||
|
2018
Q2 | $604K | Hold |
|
|||||
|
2018
Q1 | $678K | Hold |
|
|||||
|
2017
Q4 | $787K | Buy |
|